| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.937672 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240724151156 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 240502t20242024oncd ob f000 0 eng d |
|---|
| 020 | |a9780660717234 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-286/2024E-PDF |
|---|
| 245 | 00|aUse of measles-mumps-rubella (MMR) vaccine for the management of mumps outbreaks in Canada. |
|---|
| 250 | |a[Revised 2024 edition]. |
|---|
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (54 pages) : |bgraphs |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Revised publication: 2024." |
|---|
| 500 | |aIssued also in French under title: Utilisation du vaccin contre la rougeole, la rubéole et les oreillons (RRO) pour la prise en charge des éclosions d'oreillons au Canada. |
|---|
| 500 | |aAt head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). |
|---|
| 500 | |a"Notice to reader: The errors in the references have been corrected." |
|---|
| 504 | |aIncludes bibliographical references (pages 33-39). |
|---|
| 520 | |a"This Statement provides an evidence summary and recommendations on the topic of additional dose(s) of MMR vaccine provided in mumps outbreak settings, including the off-label administration of a third dose of MMR vaccine (MMR3) in individuals who were previously vaccinated with two valid doses, for consideration by public health programs"--Page 4. |
|---|
| 650 | 0|aMumps|xVaccination|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
|---|
| 775 | 08|tUtilisation du vaccin contre la rougeole, la rubéole et les oreillons (RRO) pour la prise en charge des éclosions d'oreillons au Canada.|w(CaOODSP)9.937673 |
|---|
| 795 | |tUse of measles-mumps-rubella (MMR) vaccine for the management of mumps outbreaks in Canada.|b[July 2021 edition]|w(CaOODSP)9.898655 |
|---|
| 856 | 40|qPDF|s1,009 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP40-286-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/use-measles-mumps-rubella-vaccine-management-outbreaks-canada.html |
|---|
| 986 | |a240116 |
|---|